NFKB1 and cancer: Previously, CD10 has been reported to be expression in cancer-associated fibroblasts, CD10+GPR77+ CAFs enhance tumor growth and resistance to chemotherapy by supporting CSCs, which is sustained by continuous NF-κB activation through p65 phosphorylation and acetylation 34.